Evolus, Inc.
EOLS

$900.24 M
Marketcap
$14.22
Share price
Country
$-0.11
Change (1 day)
$17.82
Year High
$9.25
Year Low

Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

marketcap